Demand for APAC clinical trials is still on the rise as COVID numbers continue to fall across the region attracting biotechs wanting to restart stalled or paused clinical trials from around the globe. Indeed Australia recorded zero new cases in the past 25 days.
Find out why industry partnerships matter in the APAC region. The relationships biotechs need to streamline the clinical process and take advantage of the exceptional start-up timeframes on offer. Discover how to check that your clinical partners have the right relationship credentials and alliances. Most importantly learn how to avoid a trial rescue crisis by ensuring you are working with a connected network of industry leaders.